TipRanks
Advertisement
Advertisement

DE:C5G Stock Latest News

Orexo to Present Q3 2026 Interim Results in Live Investor Call
Company AnnouncementsOrexo to Present Q3 2026 Interim Results in Live Investor Call
15h ago
Orexo’s AmorphOX® tech shows promising oral semaglutide bioavailability
PremiumCompany Announcements
Orexo’s AmorphOX® tech shows promising oral semaglutide bioavailability
3d ago
Orexo launches 250 MSEK rights issue to fund pipeline and strengthen finances
PremiumCompany Announcements
Orexo launches 250 MSEK rights issue to fund pipeline and strengthen finances
11d ago
Orexo convenes EGM to approve rights issue and capital authorizations
PremiumCompany Announcements
Orexo convenes EGM to approve rights issue and capital authorizations
11d ago
Orexo Resubmits High-Dose Opioid Overdose Rescue Drug IZIPRY for FDA Review
PremiumCompany Announcements
Orexo Resubmits High-Dose Opioid Overdose Rescue Drug IZIPRY for FDA Review
17d ago
Orexo Wins FDA Green Light to Advance Needle‑Free Anaphylaxis Treatment OX640
PremiumCompany AnnouncementsOrexo Wins FDA Green Light to Advance Needle‑Free Anaphylaxis Treatment OX640
1M ago
Orexo Wins BARDA Funding Boost to Extend OX390 Overdose Rescue Development
Premium
Company Announcements
Orexo Wins BARDA Funding Boost to Extend OX390 Overdose Rescue Development
1M ago
Orexo CFO Fredrik Järrsten to Step Down as Company Streamlines Operations
Premium
Company Announcements
Orexo CFO Fredrik Järrsten to Step Down as Company Streamlines Operations
2M ago
Orexo Moves to Settle U.S. DOJ Probe With Non‑Prosecution Deal
PremiumCompany Announcements
Orexo Moves to Settle U.S. DOJ Probe With Non‑Prosecution Deal
2M ago
Orexo AB Earnings Call: Science Progress, Cash Strain
PremiumCompany Announcements
Orexo AB Earnings Call: Science Progress, Cash Strain
3M ago
Orexo Advances Nasal Rescue Pipeline as Losses Deepen in Q2 2026
PremiumCompany Announcements
Orexo Advances Nasal Rescue Pipeline as Losses Deepen in Q2 2026
3M ago
Orexo strengthens partnership strategy with new business development chief
PremiumCompany Announcements
Orexo strengthens partnership strategy with new business development chief
4M ago
Orexo posts positive in‑vivo data for nasal overdose reversal candidate OX390
PremiumCompany AnnouncementsOrexo posts positive in‑vivo data for nasal overdose reversal candidate OX390
5M ago
Orexo AGM Backs Board, Expands Capital Flexibility and Incentive Plans
Premium
Company Announcements
Orexo AGM Backs Board, Expands Capital Flexibility and Incentive Plans
5M ago
Orexo Deepens R&D Push as Losses Widen and Bond Redeemed Early
Premium
Company Announcements
Orexo Deepens R&D Push as Losses Widen and Bond Redeemed Early
6M ago
Orexo updates share and voting structure after class C conversion
PremiumCompany Announcements
Orexo updates share and voting structure after class C conversion
7M ago
Orexo Calls 2026 AGM to Decide on Governance, Capital Measures and Incentive Plan
PremiumCompany Announcements
Orexo Calls 2026 AGM to Decide on Governance, Capital Measures and Incentive Plan
7M ago
Orexo Publishes 2025 Annual and Sustainability Reports Detailing Strategy and Market Position
PremiumCompany Announcements
Orexo Publishes 2025 Annual and Sustainability Reports Detailing Strategy and Market Position
7M ago
Orexo Restructures Leadership to Drive Pipeline and AmorphOX-Focused Growth
PremiumCompany Announcements
Orexo Restructures Leadership to Drive Pipeline and AmorphOX-Focused Growth
7M ago
Orexo to Redeem SEK 500m Social Bonds After Zubsolv Rights Sale
PremiumCompany AnnouncementsOrexo to Redeem SEK 500m Social Bonds After Zubsolv Rights Sale
8M ago
Orexo Adjusts Share Structure After U.S. Zubsolv Divestment
Premium
Company Announcements
Orexo Adjusts Share Structure After U.S. Zubsolv Divestment
8M ago
Orexo Boosts Cash and Earnings After USD 91 Million Zubsolv US Sale
Premium
Company Announcements
Orexo Boosts Cash and Earnings After USD 91 Million Zubsolv US Sale
8M ago

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >